| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 09/27/2006 | EP1704143A1 Malononitrile compound as pesticides |
| 09/26/2006 | US7112679 Convergent synthesis of α-aryl-β-ketonitriles |
| 09/26/2006 | US7112554 Herbicides; broad active spectrum; on soil and above ground plant parts use |
| 09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/21/2006 | US20060211725 Use |
| 09/20/2006 | EP1509491B1 Intermediate products, methods for their preparation and use thereof |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/19/2006 | US7109377 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 09/14/2006 | WO2006096564A1 Fused aromatic compounds having anti-diabetic activity |
| 09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 09/14/2006 | US20060205794 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant |
| 09/14/2006 | US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide |
| 09/13/2006 | EP1699783A1 Opioid receptor antagonists |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1097925B1 Novel benzoic acid derivatives and processes for the preparation thereof |
| 09/13/2006 | CN1833003A Sulfonamide anions as catalysts for nco oligomerization |
| 09/13/2006 | CN1832944A Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105557 Polymorphs of valsartan |
| 09/08/2006 | WO2006076575A3 Substituted biaryl compounds as factor xia inhibitors |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1697334A1 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | US7101897 Farnesyl transferase inhibitors |
| 08/31/2006 | WO2006090234A1 Heterocyclic derivatives as cell adhesion inhibitors |
| 08/31/2006 | WO2006090052A1 Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof |
| 08/31/2006 | US20060194861 e.g. 1-(1-cyclohexyl-5-(4-(methylsulfonyl)phenyl)pyrazol-3-yl)-4-hydroxybutan-1-one; antiinflammatory agent, analgesic, antipyretic, wound healing agents; gastrointestinal disorders; side effect reduction |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | CA2597781A1 Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof |
| 08/30/2006 | EP1695705A1 Compounds effecting glucokinase |
| 08/30/2006 | EP1694655A2 Phosphodiesterase inhibitors |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | CN1826330A Combretastatin derivatives with cytotoxic action |
| 08/30/2006 | CN1826324A Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 08/29/2006 | CA2240735C Process for production of piperidine derivatives |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006089177A2 Isoxazole combretastin derivatives for the treatment of disorders |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |
| 08/24/2006 | US20060189808 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/24/2006 | US20060189668 Method of treating hyperproliferative disorders using heterocyclic inhibitors of MEK |
| 08/24/2006 | US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer |
| 08/24/2006 | US20060189649 Mitogen activated protein kinase inhibitors such as 6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methylbenzo[d]isoxazole-5-carboxylic acid (2-hydroxyethoxy)-amide, used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/23/2006 | EP1692127A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1368358B1 Isoxazoline derivatives as anti-depressants |
| 08/23/2006 | EP1027328B1 Substituted anilides |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094903 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094777 5-HT2A receptor ligands |
| 08/17/2006 | WO2006085212A2 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv |
| 08/17/2006 | WO2006084688A1 HIV protease inhibitors |
| 08/17/2006 | WO2006037982A3 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | CA2594395A1 Hiv protease inhibitors |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689389A2 Indole compounds |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | CN1820006A Substituted oxyarenes, and use thereof for controlling pests |
| 08/16/2006 | CN1269800C Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091199 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1687314A1 PREPARATION OF 1-AZA-2-OXA-DIBENZO [e,h] AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 08/09/2006 | EP0877733B1 Process for production of piperidine derivatives |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087630 Cyclooxygenase 2 selective inhibitors, compositions and methods of use |
| 08/08/2006 | US7087598 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/03/2006 | WO2005095361A8 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 08/03/2006 | WO2005060456A8 Method for treating adamts-5-associate disease |
| 08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
| 08/03/2006 | US20060173024 Compositions and methods for treating heart failure |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
| 08/02/2006 | EP1684752A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 08/02/2006 | EP0970935B1 Method of separating optical isomers |
| 08/02/2006 | CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 08/01/2006 | US7084163 Applying to plants |
| 07/27/2006 | WO2006034333A3 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |